Respiratory Distress Syndrome, Acute
6
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
7 treatments under study, led by Bioelectrical Impedance Vector Analysis Biva
Research Leaders
9 sponsors active, led by University-Town Hospital of Chongqing Medical University
Related Conditions
Often studied with 15 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (6)
A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)
Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS
Multimodal Database and Large Language Model for ARDS
Implementation of Lung Protective Ventilation in Patients With Acute Respiratory Failure
Bioelectrical Impedance in Monitoring Hyperhydration and Polyneuromyopathy in Critically Ill Patients
Extended Prone Position Duration COVID-19-related ARDS: a Retrospective Study
Research Network
Common Treatments
- Bioelectrical Impedance Vector Analysis Biva1
- Blood And Urine Analysis1
- Clinical Data And Biospecimen Collection1
- Cumulative Water Balance1
- Dexamethasone1
Active Sponsors
- University-Town Hospital of Chongqing Medical University1
- Children's Hospital of Chongqing Medical University1
- Intermountain Health Care, Inc.1
- GEn1E Lifesciences1
- University Hospital Ostrava1
Top Investigators
Assistance Publique - Hôpitaux de Paris
Intermountain Health Care, Inc.
GEn1E Lifesciences
The Second Affiliated Hospital of Chongqing Medical University
University Hospital Ostrava
Related Conditions
- Respiratory Insufficiency2
- Acute Respiratory Distress Syndrome2
- Chronic Obstructive Pulmonary Disease Exacerbation1
- Shock Lung1
- Severe Communityacquired Pneumonia1